Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells.
about
Interferon lambda: a new sword in cancer immunotherapyA role for IFN-lambda1 in multiple myeloma B cell growthIFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activityIFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production.Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1Interferon-lambdas: the modulators of antivirus, antitumor, and immune responsesCytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis.Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.Interferon-λ in HCV Infection and Therapy.Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.Functional characterization of canine interferon-lambdaRegulatory effects of ribosomal S6 kinase 1 (RSK1) in IFNλ signalingInterferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells.Adenoviruses-mediated transduction of human oesophageal carcinoma cells with the interferon-λ genes produced anti-tumour effectsInterleukin 31 mediates MAP kinase and STAT1/3 activation in intestinal epithelial cells and its expression is upregulated in inflammatory bowel disease.Interferon-λ1 suppresses invasion and enhances autophagy in human osteosarcoma cell.Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells.A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects.Investigations of interferon-lambda for the treatment of cancer.Targeting IFN-λ: therapeutic implications.IFN-λ cancer immunotherapy: new kid on the block.Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer.Interleukin 29 enhances expression of Toll receptor 3 and mediates antiviral signals in human keratinocytes.Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosis.Tanapoxvirus lacking the 15L gene inhibits melanoma cell growth in vitro by inducing interferon-λ1 release.IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.Impact of interleukin-28B genotype on in vitro and in vivo systems of hepatitis C virus replication.Mutation of IFNLR1, an interferon lambda receptor 1, is associated with autosomal-dominant non-syndromic hearing loss.Dexamethasone decreases IL-29 expression in house dust mite-stimulated human bronchial epithelial cells.Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways.Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.The effect of IL-28A on human cord blood CD4+ T cells.
P2860
Q21296797-D2906BC2-5083-4825-B75E-68F8FB3D55E8Q24645649-8C0D7BE1-909B-484B-AD7B-AF2840E8C400Q24651982-419D8BF4-4E2B-4C10-9138-81E964594556Q27308880-A74E3CA1-9A47-484A-8790-B98CE83B7492Q27664960-D5ECAE43-9240-4771-998F-BC7171332E4DQ28238963-0AB3AD62-47E8-4C12-A81C-7861DD7334FFQ30873949-5D34E8FF-DEB7-4877-A50A-0ABADFD86E3CQ33775597-01F669DB-341D-4BDE-8C59-E96966F95B9FQ34047500-1EF43401-FF97-4161-91FF-0E1B303C23B7Q34409699-961DF6AC-30DF-4007-9C75-F38F77B896E3Q34439979-256B0889-006F-4929-8B07-0CAAFEB943BBQ34488887-1CAF51DD-8D19-4927-A748-CD15DED21DDEQ34734013-DC19A982-101E-48D9-8D66-47C1C78381AFQ35620657-FE79FBE3-099E-4622-9C4E-60533047FDE8Q35954120-AC6CB29E-6468-4DCB-9DBD-DD36212EA48FQ36317399-5EFD49F2-C965-406E-9408-6B2705F84039Q36630086-299DF8CE-0F08-4A89-878E-0B494165456BQ37947594-97D1DEB1-001F-4F50-A11E-2582B485A445Q38347596-B6FCA7C2-FE03-431D-AD79-BED2A0156699Q38816811-51F661CA-24DE-4543-9F5A-884E320BAD9AQ38887297-82ED6A0F-B59E-43BF-B3AB-9D69AAFC2A20Q39480969-F9E4363F-6963-4D4D-A758-0FF1D38A84BEQ39489291-0C93478D-DDFD-4681-AE13-CDD36B979DE6Q39747657-83EA3528-B595-44B1-B1E0-146DB0C6300CQ40336558-5D8AD84A-11FE-4BF0-B634-CEFBEC7A39FAQ45351150-DDF1BF09-B781-45B4-8B01-470577AC73E2Q45358158-E15127F9-C17B-40C6-AB80-AED6B1D4C4CDQ49915030-C4C45278-7ECC-4027-95BD-5FF8E5DBCDDCQ53243459-57B49BA5-E909-4E33-A1B2-01AEC9360553Q53327148-F50C6C12-4610-48FC-B94B-74BBB94B2C93Q53404199-D83424AB-C9B3-429E-A643-878117E946AAQ54441842-694B0F1E-0AD9-4BB5-81CB-8004CD693474
P2860
Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells.
@en
type
label
Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells.
@en
prefLabel
Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells.
@en
P2093
P1476
Novel interferon-lambdas induce antiproliferative effects in neuroendocrine tumor cells.
@en
P2093
Burkhard Göke
Christoph J Auernhammer
Gerald Spöttl
Heinrich Meyer
Jennifer Meinecke
Kathrin Zitzmann
Sebastian Baehs
Stephan Brand
P304
P356
10.1016/J.BBRC.2006.04.043
P577
2006-04-24T00:00:00Z